These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11508155)

  • 1. [Horton's disease in elderly patients aged over 75: clinical course, complications of corticotherapy. Comparative study of 164 patients. Towards a reduced initial dose].
    Chevalet P; Barrier JH; Glémarec J; el Kouri D; Hamidou M; de Wazières B; Duhamel E; Jégo P; Maugars Y; Planchon B; Rodat O
    Rev Med Interne; 2001 Jul; 22(7):624-30. PubMed ID: 11508155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients.
    Chevalet P; Barrier JH; Pottier P; Magadur-Joly G; Pottier MA; Hamidou M; Planchon B; El Kouri D; Connan L; Dupond JL; De Wazieres B; Dien G; Duhamel E; Grosbois B; Jego P; Le Strat A; Capdeville J; Letellier P; Agron L
    J Rheumatol; 2000 Jun; 27(6):1484-91. PubMed ID: 10852275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-complicated Horton's disease: initial treatment with methylprednisolone 500 mg/day bolus for three days followed by 20 mg/day prednisone-equivalent. Evaluation of 15 patients].
    Sailler L; Carreiro M; Ollier S; Juchet H; Delobel P; Ferrand D; Klinger M; Arlet P
    Rev Med Interne; 2001 Nov; 22(11):1032-8. PubMed ID: 11817115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bolus of methylprednisolone and Horton's disease/rhizomelic pseudo-polyarthritis. Preliminary results of a pilot study of treating the bolus with low doses of corticoids].
    Juchet H; Arlet P; Ollier S; Montané de la Roque P; Le Tallec Y
    Ann Med Interne (Paris); 1992; 143(2):85-8. PubMed ID: 1530225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis: a retrospective study.
    Nesher G; Rubinow A; Sonnenblick M
    Clin Exp Rheumatol; 1997; 15(3):303-6. PubMed ID: 9177927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Simple Horton's syndrome: modalities of treatment].
    Agard C; Barrier JH
    Presse Med; 2004 Jan; 33(1):41-50. PubMed ID: 15026724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Principles of acute treatment of Horton's disease. Role of high-dose corticosteroid therapy].
    Barrier JH; Chevalet P; Ponge T
    Ann Med Interne (Paris); 1998 Nov; 149(7):448-53. PubMed ID: 9921399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.
    Jover JA; Hernández-García C; Morado IC; Vargas E; Bañares A; Fernández-Gutiérrez B
    Ann Intern Med; 2001 Jan; 134(2):106-14. PubMed ID: 11177313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).
    Spiera RF; Mitnick HJ; Kupersmith M; Richmond M; Spiera H; Peterson MG; Paget SA
    Clin Exp Rheumatol; 2001; 19(5):495-501. PubMed ID: 11579707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Audit of the management of suspected giant cell arteritis in a large teaching hospital.
    Dalbeth N; Lynch N; McLean L; McQueen F; Zwi J
    Intern Med J; 2002 Jul; 32(7):315-9. PubMed ID: 12088349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
    van der Veen MJ; Dinant HJ; van Booma-Frankfort C; van Albada-Kuipers GA; Bijlsma JW
    Ann Rheum Dis; 1996 Apr; 55(4):218-23. PubMed ID: 8733437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of medium-dose prednisone in giant cell arteritis: a retrospective cohort study of 103 patients.
    Les I; Pijoán JI; Rodríguez-Álvarez R; Ruiz-Irastorza G; Martínez-Berriotxoa A
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-90-7. PubMed ID: 26016756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis.
    Hernández-Rodríguez J; García-Martínez A; Casademont J; Filella X; Esteban MJ; López-Soto A; Fernández-Solà J; Urbano-Márquez A; Grau JM; Cid MC
    Arthritis Rheum; 2002 Feb; 47(1):29-35. PubMed ID: 11932875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis of treated temporal arteritis. Retrospective study of 87 cases].
    Gouet D; Maréchaud R; Le Berre D; Alcalay M; Becq-Giraudon B; Boissonnot L; Bontoux D; Gil R; Lefevre JP; Risse JF
    Presse Med; 1986 Mar; 15(13):603-6. PubMed ID: 2939417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Giant cell arteritis after the age of 75].
    Chevalet P; Masseau-Imbert A; Durand-Fix MH; Agard C; Brisseau JM; Rodat O; Barrier JH
    Ann Med Interne (Paris); 2002 Oct; 153(6):373-7. PubMed ID: 12486385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of non-complicated Horton's disease].
    Sailler L; Juchet H; Arlet P
    Rev Prat; 1999 Mar; 49(6):613-7. PubMed ID: 10218398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Induction therapy with corticoid pulses for treatment of temporal arteritis].
    Krüger K
    Z Rheumatol; 2007 Mar; 66(2):165-6. PubMed ID: 17294060
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complicated Horton's syndrome: therapeutic modalities].
    Agard C; Barrier JH
    Presse Med; 2004 Jan; 33(1):51-9. PubMed ID: 15026725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment.
    Hwang JM; Girkin CA; Perry JD; Lai JC; Miller NR; Hellmann DB
    Am J Ophthalmol; 1999 Jan; 127(1):102-4. PubMed ID: 9933015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.